De Martin, Angelina
Stanossek, Yves
Lütge, Mechthild http://orcid.org/0000-0001-9011-5319
Cadosch, Nadine
Onder, Lucas
Cheng, Hung-Wei
Brandstadter, Joshua D. http://orcid.org/0000-0003-0652-5791
Maillard, Ivan http://orcid.org/0000-0003-1312-6748
Stoeckli, Sandro J.
Pikor, Natalia B. http://orcid.org/0000-0002-6564-4232
Ludewig, Burkhard http://orcid.org/0000-0002-7685-573X
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (182583, 177208, 180011)
Research Commission of the Kantonsspital St.Gallen grant no. 19/07
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (T32-HL07439)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01-AI091627)
Article History
Received: 2 May 2022
Accepted: 3 April 2023
First Online: 18 May 2023
Competing interests
: H.-W.C., L.O., N.B.P. and B.L. are founders and shareholders of Stromal Therapeutics. L.O. and B.L. are members of the board of Stromal Therapeutics. All other authors declare no competing interests.